go 6976 and acetylleucyl-leucyl-norleucinal

go 6976 has been researched along with acetylleucyl-leucyl-norleucinal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Abe-Dohmae, S; Hayashi, M; Ikeda, Y; Matsuo, M; Okuhira, K; Ueda, K; Yokoyama, S1

Other Studies

2 other study(ies) available for go 6976 and acetylleucyl-leucyl-norleucinal

ArticleYear
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein.
    The Journal of biological chemistry, 2004, Jan-02, Volume: 279, Issue:1

    Topics: Apolipoprotein A-I; Apolipoproteins; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Bucladesine; Carbazoles; Cell Line; Cholesterol; Cloning, Molecular; Cysteine Proteinase Inhibitors; DNA, Complementary; Enzyme Inhibitors; Humans; Indoles; Kinetics; Leupeptins; Lipoproteins, HDL; Phospholipids; Recombinant Proteins; Tetradecanoylphorbol Acetate; Transfection

2004